Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 1
1(25.0%)
4Total
N/A(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02753959Not ApplicableCompleted

Changes in Regional Lung Ventilation Following Mechanical Insufflation-Exsufflation

Role: collaborator

NCT02763631Not ApplicableCompleted

Symptomatic Treatment of Excessive Dynamic Airway Collapse Using Daytime Portable Continuous Positive Airway Pressure

Role: collaborator

NCT02765360Not ApplicableCompleted

EIT Study With COPD and OHS Patients (EIT Step 2)

Role: collaborator

NCT02828007Phase 1Completed

EIT Study With Healthy Patients

Role: collaborator

All 4 trials loaded